Glenn Goldberg

Helping startups, growth-stage, and mid-market companies build, scale, and accelerate their brands in the U.S. market. I partner with founders and executive teams as a Fractional CMO and strategic marketing advisor, delivering senior-level leadership and Fortune 500 rigor with an entrepreneurial mindset and hands-on execution, that drives measurable results. Core Services: ★ Fractional CMO & Marketing Leadership ★ Brand Positioning & Go-to-Market Strategy ★ US Market Entry & Commercial Readiness ★ Omni channel Marketing (Retail, Amazon, DTC, Digital Media) ★ Innovation & Product Launch Strategy ★ Business Turnarounds and Brand Revitalization

Member of the Board of Directors for Propedix, a biopharma and consumer health company dedicated to advancing innovative treatments in healthcare. Our flagship product, featuring our breakthrough anti-fungal and drying agent technology, launched in Q1 2025, with a pipeline of advanced OTC and Rx treatments in dermatology and health. Driven by strong research and development, we’re delivering the next generation of health solutions.

Worked with Founders, as Executive leadership team member overseeing all marketing and brand management for the Home & Office portfolio, including the Mind Reader and EZ Board brands. ★ Strategy & Repositioning: Led the full rebrand of Mind Reader—from consumer insights and positioning to visual identity, logo, tagline, creative development, and messaging. ★ Integrated Marketing Execution: Developed and executed 2024 go-to-market plans including digital strategy, Amazon, PR, social media, influencer partnerships, content, and streaming TV. Delivered +25% sales growth and 5B+ impressions. ★ Growth Acceleration: Scaled EZ Board brand +140% through high-impact PR, influencer activations, and social-led campaigns. ★ Innovation Leadership: Conceived and led a new business initiative projected to exceed $25M in retail sales, overseeing product development, feasibility, market research, and commercial launch planning.

Member of the North American Leadership Team and Head of Marketing for a PE-backed consumer health company, driving transformational growth across core OTC brands and leading a breakthrough Rx-to-OTC switch initiative. ★ Growth Leadership: Led the marketing team behind the accelerated performance of Mederma and Compeed, delivering +45% sales growth and +20% EBIT improvement through full-funnel, omnichannel strategies. ★ Marketing Execution: Oversaw development and execution of comprehensive brand plans using Linear TV, PR, OLV, CTV, social media, influencers, SEO/SEA, DSP, and shopper activations to drive performance across Amazon, Retail, and Digital channels. ★ Brand Innovation: Served as Commercial Lead for OPILL—the first FDA-approved daily oral contraceptive available OTC in the U.S.—projected to generate $75M+ in incremental retail sales. Company acquired by Perrigo in April 2022 for $2.1B, 18x EBITDA

Led global brand strategy, commercial expansion, and innovation pipeline for the Nexium OTC franchise—driving revenue growth, geographic expansion, and consumer-driven product development in a complex, regulated environment. ★ Led global commercialization strategy for Nexium's Rx-to-OTC switch across Latin America, Asia-Pacific, and EMEA, targeting a +70% revenue lift by 2023. Oversaw regional market assessments, regulatory evaluations, and localized go-to-market strategies in collaboration with in-country teams. ★ Directed brand vision, equity management, and full-funnel marketing communications (including all playbooks and tool kits; Consumer & HCP) —ensuring consistent global brand alignment while enabling local market execution. ★ Evaluated and prioritized OTC switch candidates, leading commercial due diligence, consumer insight testing, and packaging/labeling strategies to identify viable, high-potential products for future OTC conversion. ★ Led strategic innovation roadmap that uncovered a new digestive health territory with a projected $360M in incremental revenue—aligning unmet consumer needs with commercial opportunity and brand scalability.

Held full commercial leadership for the Store Brand and Consumer OTC division, overseeing Sales, Marketing, and Business Development. Reversed declining performance and established a scalable growth engine through strategic brand building, M&A, product innovation, and channel expansion. ★ Revitalized a declining business, delivering +10% sales growth and +14% profit improvement by redefining operating strategy, optimizing product mix and pricing, and unlocking new customer and channel opportunities. ★ Created strategic vision and roadmap, aligning short- and long-term growth initiatives. Built a robust new product pipeline and originated business development ventures that unlocked $80M+ in future revenue potential. ★ Led acquisition and relaunch of the FeverAll brand, overseeing all aspects of brand strategy, packaging redesign, retail marketing, and sales execution—resulting in +300% sales growth and expanded national retail footprint. ★ Formed a joint venture with Kamedis Dermatology, leading commercial modeling, brand positioning, marketing strategy, and sales execution. Successfully launched the brand in the U.S., achieving national distribution in 5,000+ retail locations within the first year.

Led the transformation of the General Eye Care business for a private equity–backed consumer health company, driving brand revitalization, new product innovation, and operational excellence—culminating in a successful $8.7B acquisition by Valeant Pharmaceuticals in 2013. ★ Architechted and rolled out integrated marketing campaigns that directly contributed to a +17% increase in sales and +112% lift in operating profit—repositioning the brand for sustained growth. ★ Developed a 5-year strategic roadmap and financial growth plan, identifying whitespace opportunities and innovation platforms that delivered a +31% CAGR across the portfolio. ★ Launched multiple new products and executed full packaging redesigns that elevated shelf presence and brand equity, while securing secondary retail placement and improving category visibility.

Retail Innovation | Tech-Enabled Expansion | Omni-Channel Marketing | P&L Growth Promoted to lead a newly created Strategic Business Unit following the successful launch of the Dr. Scholl’s Custom Fit Orthotics Kiosk (which I led the creation of in a prior role). Oversaw national and international expansion, full P&L responsibility, and end-to-end go-to-market strategy across retail, marketing, and operations. ★ Led cross-functional expansion strategy across the U.S., Canada, and Latin America—launching in 4,500+ U.S. locations and 100 in Canada. ★ Built and operationalized supply chain infrastructure, including kiosk installation, service, and maintenance models—ensuring scalable, cost-effective deployment. ★ Developed analytics-driven performance framework to evaluate kiosk productivity, optimize location strategy, and drive placement decisions based on ROI and consumer demand patterns. ★ Led in-depth consumer experience research, identifying friction points and behavioral drivers that led to a 30% increase in conversion rates at point-of-sale. ★ Directed strategy, creative development, and execution of a new national TV campaign, supporting kiosk education and brand awareness across core retail partners. ★ Created long-term roadmap for product innovation, claims development, and kiosk optimization—positioning the platform for future growth and personalization. ★ Achieved +14% revenue growth and +144% profit growth, driving category leadership with +55% growth in the insole segment and +24% growth in overall footcare.

Led new entrepreneurial venture and created the “game changing” Dr. Scholl’s® Custom Fit® Orthotics Kiosk, a breakthrough retail innovation that redefined the insole category and created a scalable new business model. ★ Developed the concept, and led the strategic and creative development, execution, and all marketing and sales efforts. This included the creation of an interactive visual merchandising display, software design, consumer interface, FootMapping® technology, as well as a new line of 14 products, nomenclature, packaging and graphics design. ★ Created TV Advertising and Marketing campaign, gained retailer acceptance and launched into 100 store, 4 Market Test. ★ Achieved record-breaking sales, growing Insoles and Footcare category by +212% and +42% respectively.

★ Responsible for company's largest brand portfolio. Led large cross functional team and developed brand plans, new TV advertising, PR campaign, multiple new product and flavor launches, and in store merchandising efforts. ★ Increased sales and profit by +10% and +5% respectively.

★ Developed overall strategic plan for cocktail mixer portfolio (Mr. & Mrs. T’s, Holland House, Margaritaville, and Roses Cocktail Mixers) including development and execution all aspects of multi faceted brand restage, which included new package design, graphics, multiple product formulation, advertising, and product innovation. ★ Reversed declines and grew sales and profit by +8% and +5% respectively.

★ Led the acquisition of the Mauna Lai brand, and developed new positioning, packaging and graphics, marketing and promotional support plans, achieving sales and profit growth of +6% and +4% respectively.

★ Led the development of marketing plans launched several new flavor assortments. Grew sales and profit by +8% and +3% respectively.

Managed Marketing responsibilities for $100M Pepperidge Farm Frozen portfolio. ★ Led cross functional teams for brand redesigns and successful new product launches for Texas Toast Garlic Breads, Pot Pies, and Frozen French Toast.